Tight junction physiology of pleural mesothelium by Alexander G. Markov & Salah Amasheh
REVIEW ARTICLE
published: 24 June 2014
doi: 10.3389/fphys.2014.00221
Tight junction physiology of pleural mesothelium
Alexander G. Markov1 and Salah Amasheh2*
1 Department of General Physiology, St. Petersburg State University, St. Petersburg, Russia
2 Department of Veterinary Medicine, Institute of Veterinary Physiology, Freie Universität Berlin, Berlin, Germany
Edited by:
Sotirios G. Zarogiannis, University of
Thessaly, Greece
Reviewed by:
Alexi Alekov, Medizinische
Hochschule Hannover, Germany
Jose L. Reyes, National Polytechnic
Institute, Mexico
*Correspondence:
Salah Amasheh, Institute of
Veterinary Physiology, Oertzenweg
19b, 14163 Berlin, Germany
e-mail: salah.amasheh@fu-berlin.de
Pleura consists of visceral and parietal cell layers, producing a fluid, which is necessary for
lubrication of the pleural space. Function of both mesothelial cell layers is necessary for the
regulation of a constant pleural fluid volume and composition to facilitate lung movement
during breathing. Recent studies have demonstrated that pleural mesothelial cells show
a distinct expression pattern of tight junction proteins which are known to ubiquitously
determine paracellular permeability. Most tight junction proteins provide a sealing function
to epithelia, but some have been shown to have a paracellular channel function or
ambiguous properties. Here we provide an in-depth review of the current knowledge
concerning specific functional contribution of these proteins determining transport and
barrier function of pleural mesothelium.
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INTRODUCTION
Pleura, peritoneum and pericardium are squamous epithelia of
mesothelial origin, which line lungs, chest cavity, abdomen, and
heart, respectively. Pleura can be divided in the pleura visceralis
or pleura pulmonalis covering lungs, and pleura parietalis cov-
ering the ribs. Both are delimitated by a single layer of epithelial
cells which attach to a lamina propria, and have different func-
tions regarding transport and barrier properties. Between the two
layers, the pleura cavity is located (Figure 1). The pleura provides
a fluid layer for lung movement, and therefore is necessary for
breathing This small volume of pleural liquid is a result of filtra-
tion and absorptive processes, and its volume and composition is
tightly regulated (Zocchi, 2002). An imbalance of this regulation
can result in an accumulation of fluid between the parietal and
the visceral pleura, a condition defined as pleural effusion (Light,
1997).
The difference between hydrostatic and colloid-osmotic pres-
sure of pleural liquid and capillary blood results in filtration
of pleural liquid in the pleural cavity. In caudal parietal pleura,
the elimination of liquid from a pleural cavity occurs through
lymphatic vessels. In this context, further mechanisms related
to mesothelial cell activity have been discussed to be more rel-
evant, including a solute-coupled absorption of liquid from the
pleural space (Zocchi, 2002). However, vectorial transport across
epithelia depends on a concerted action of transcellular trans-
port mechanisms in combination with paracellular channel and
barrier functions, and several transcellular transport mechanisms
have been identified to participate in the formation of pleural liq-
uid. For analysis, electrophysiological measurements have been
performed in different species including man (Hatzoglou et al.,
2001; Sarkos et al., 2002; Kouritas et al., 2008; Markov et al.,
2011). Moreover, the molecular correlate of paracellular chan-
nel and barrier function has been discovered in recent years,
namely the tight junction (TJ) which shows a tissue specific
expression of tight junction proteins determining the functional
properties of the tissues (for review, see e.g., Amasheh et al., 2011;
Rosenthal et al., 2012). Neighboring epithelial cells are linked
together by these structures, which show a distinct strand pat-
tern in freeze fracture electron micrographs (Staehelin, 1973).
Typically tight junctions are located between the apical and the
basolateral membrane of epithelial cells, providing not only a
gate function describing the role for paracellular permeability, but
also a fence function which is a prerequisite for polarity of the
cells, as it delimits diffusion of basolateral and apically located
integral membrane molecules to the opposite membrane com-
partment, respectively (Tsukita et al., 2001). Taken together, both
transcellular and paracellular determinants of transport and bar-
rier function can be regarded to contribute to the generation of
different ionic composition of pleural fluid compared to plasma
(Table 1).
Furthermore, inflammation was identified as onemajor mech-
anism perturbing barrier integrity, as shown previously in inflam-
matory bowel diseases (Amasheh et al., 2009a). In this context,
also an effect of pleura inflammation on tight junction proteins
was observed (Markov et al., 2011).
TRANSPORT AND BARRIER MECHANISMS IN PLEURA
MESOTHELIUM
ELECTROPHYSIOLOGICAL PROPERTIES OF PLEURA MESOTHELIUM
In Ussing chambers, transmesothelial potential (Vm), and trans-
mesothelial resistance (Rm) have been reported. The experiments
revealed differences concerning absolute values, which might
be attributed to different specimens and preparative protocols.
However, these differences were rather marginal and in compar-
ison with studies focusing on established epithelial models of
kidney and intestine (Amasheh et al., 2002; Markov et al., 2010),
these values indicated rather leaky properties of both, visceral and
parietal pleura (Table 2).
The existence of electrophysiological parameters indicates
transport and barrier mechanisms, as transmesothelial transport
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FIGURE 1 | Orientation of visceral and parietal pleura mesothelium.
Table 1 | Comparison of ionic composition of pleural fluid and plasma.
Ion Pleural fluid Plasma Species References
Na+ 139 (141*) 142 (151*) Rabbit,
anesthesia
Zocchi et al., 1991
141 149 Rats, no
anesthesia
Rolf and Travis, 1973
K+ 4.48 4.42 Rabbit,
anesthesia
Zocchi et al., 1991
Cl− 96 (98*) 93 (102*) Rabbit
anesthesia
Zocchi et al., 1991
111 122 Rats, no
anesthesia
Rolf and Travis, 1973
109 113 Rabbit, no
anesthesia
Sahn et al., 1979
HCO−3 29 26 Rabbit
anesthesia
Zocchi et al., 1991
*Corrected according to the concentration of electrolytes per liter of serum
water or of pleural liquid water.
implies a transmesothelial barrier function to limit the paracel-
lular pathway during active transport mechanisms, restricting
back leak and therefore allowing vectorial transport and the
generation of gradients, as e.g., also demonstrated in human gas-
trointestinal tract before (Amasheh et al., 2009b). This functional
interplay of transport and barrier function can be identified by
transmesothelial potential measurements; Figure 2.
There are specific regional functional differences in organs
with large epithelial surface, as shown in detail for intestine and
kidney (Markov et al., 2010; Amasheh et al., 2011). In intes-
tine, this segment specific correlation of barrier properties was
analyzed by a combination of electrophysiological and molecular
analyses (Markov et al., 2010). In analogy the segmentation of dif-
ferent pleura areas may also be associated with differential barrier
properties. Electrophysiological experiments employing paracel-
lular flux markers of different masses, and protein expression
profiles allow a detailed analysis of these variations. Currently,
Table 2 | Comparison of transmesothelial potential (Vm) and
resistance (Rm) values measured in different species including human
tissue specimens.
Species Visceral pleura Parietal pleura References
Vm Rm Vm Rm
(mV) (·cm2) (mV) (·cm2)
Canine 0.06 20 0.03 22 Payne et al., 1988
Sheep 0.4 22 0.5 22 Hatzoglou et al.,
2001
– 21 – 20 Zarogiannis et al.,
2006
– – 0.5 19 (costal) Zarogiannis et al.,
2007
– – 0.6 21 (diaphragmal)Vogiatzidis et al.,
2006
– – – 38 Sarkos et al., 2002
Human – – – 26 Sarkos et al., 2002
21 (Cranial,
mediastinal)
18 (Caudal)
Kouritas et al.,
2008
1.6 14 1.3 18 Markov et al., 2011
– not provided.
FIGURE 2 | Restricted paracellular permeability as a prerequisite for
pleural transmesothelial potential. Transport routes are indicated as blue
(transcellular) and red (paracellular) arrows between apical (ap) and
basolateral (bl) compartments. The paracellular barrier is indicated as red
crosses.
different electrophysiological properties are known concerning
parts of parietal pleura, namely mediastinal, costal and diaphrag-
mal pleura. In sheep, transmesothelial resistance of costal pleura
showed a lower transmesothelial resistance than diaphragmal
Frontiers in Physiology | Membrane Physiology and Membrane Biophysics June 2014 | Volume 5 | Article 221 | 2
Markov and Amasheh Tight junction physiology of pleural mesothelium
pleura (Zarogiannis et al., 2007) whereas in human pleura, a
higher resistance of cranial pleura compared to caudal pleura was
reported (Kouritas et al., 2008; Table 2).
For analyses of pleural transport function, ouabain and
amiloride have been employed. Whereas ouabain is a selective
blocker of the—typically basolaterally located—Na+/K+-ATPase,
application of amiloride inhibits the epithelial sodium channel
(ENaC), typically located in the apical membrane. Application
of ouabain and amiloride had different effects on human parietal
pleura. Whereas in the caudal region, an increase of transme-
sothelial resistance was reported, in the cranial and mediastinal
pleura no significant ouabain effect was observed (Kouritas
et al., 2008). This apparent contradiction might indicate that
there is no generally uniform mapping, as some studies refer to
the cranial-caudal axis, and others referring to single rib areas
(Kouritas et al., 2008).
PLEURAL TRANSMESOTHELIAL TRANSPORT SYSTEMS
Transport properties have been analyzed in pleura in detail by
inducing a hydrothorax (Agostoni and Zocchi, 1990). This model
includes an injection of Ringer solution into the pleural cav-
ity to replace single ions, and the application of a variety of
blockers including ouabain and amiloride. With this technique,
a solute-coupled absorption of liquid from the pleural space
was observed (Agostoni and Zocchi, 1990; Zocchi et al., 1991).
Moreover, a general epithelial phenotype was identified, which
included the expression of the Na+/K+-ATPase. Interestingly,
the distinct localization of the Na+/K+-ATPase is not resolved
yet: Western blots revealed an expression of the Na+/K+-ATPase
a1 subunit in both, visceral and parietal pleura of rabbits, and
mesothelial primary cell culture of rabbits (Sironi et al., 2007,
2008). Existence of this subunit is characteristic for epithelia and
endothelium (Krenek et al., 2006; Gupta et al., 2012). Employing
the hydrothorax model, injection of Ringer’s solution with the
Na+/K+-ATPase blocker ouabain resulted in a reduction of water
absorption, and a decrease of ion absorption from the pleural
cavity (Agostoni and Zocchi, 1990; Zocchi et al., 1991). These
findings indicated that the Na+/K+-ATPase was located in the
apical membrane of pleural mesothelium, but a discrimination
between visceral and parietal pleura was approached only in
later experiments employing the Ussing chamber technique. In
these studies, analysis of transmesothelial resistance of different
pleural specimens with ouabain revealed differences of Na+/K+
ATPase localization in visceral and parietal pleura (Hatzoglou
et al., 2001), as ouabain induced an increase of transmesothe-
lial resistance only in visceral pleura when added to the apical
compartment, whereas in parietal pleura, an effect of ouabain
on both, the apical and basolateral side of the epithelium, was
observed.
Further evidence for the localization of Na+/K+-ATPase of
parietal pleura was found in human tissue. In Ussing chamber
experiments employing parietal pleura specimens, apical addition
of ouabain showed an effect (Kouritas et al., 2008).
As until now no immunohistochemical detection of the
localization has been published, these results cannot fully pro-
vide an evidence for localization of Na+/K+-ATPase in pleura
mesothelium, though. This still makes it difficult to define the
transcellular absorption from and secretion into the pleural cav-
ity in detail. Another indicator of typical epithelial properties is
provided by apical expression of the epithelial sodium channel
(ENaC) and exchangers, which also contribute to vectorial trans-
port. ENaC is the limiting factor for epithelial sodium absorption
in a variety of tissues and organs, including the distal nephron
and colon epithelium (Amasheh et al., 2000). For proper func-
tion in epithelia, functional co-regulation of the tight junction to
limit paracellular back leak has been reported (Amasheh et al.,
2009b).
Evidence of ENaC in parietal and visceral pleura was provided
by the hydrothorax model employing amiloride injection, which
decreased water absorption, and transport of Na+ and Cl− from
the pleural cavity (Agostoni and Zocchi, 1990; Zocchi et al., 1991).
Terbutaline, an activator of ENaC, as well as the specific ENaC
inhibitor amiloride, were injected in mice pleural cavity, leading
to an increase, and decrease of water absorption from the pleural
cavity, respectively (Jiang et al., 2003).
Application of amiloride from the apical side of human and
sheep parietal pleura increases transmesothelial resistance (Sarkos
et al., 2002; Kouritas et al., 2008). In contrast, a different group
reported that amiloride from the apical side of parietal pleura did
not change transmesothelial resistance, but increased the value
when added to the basolateral side (Hatzoglou et al., 2001).
This apparent contradiction could be resolved by Nie et al.
(2009); when ENaC was apically detected in primary culture of
human mesothelial cells and murine parietal pleura (Nie et al.,
2009). Although these studies did not include a mapping of the
expression in pleura as shown e.g., on functional level (Kouritas
et al., 2008), they might become important for the understand-
ing of pathophysiological regulatory mechanisms of transcellu-
lar pleural transport, shown for histamine and prostaglandins,
recently (Kouritas et al., 2011, 2012).
In visceral pleura, Ussing chamber studies on sheep tissue
specimens did not reveal effects of amiloride, when applied to the
apical or basolateral side, indicating no functional ENaC expres-
sion at all (Hatzoglou et al., 2001). Therefore, it remains an open
question if ENaC is localized in the apical membrane of visceral
pleura.
In pleural fluid, concentration of glucose is comparable with
blood levels. As glucose is present in the pleural space, a transport
mechanism for glucose can be expected. In accordance, Western
blotting experiments revealed expression of the sodium-glucose
linked transporter-1 (SGLT1) in visceral and parietal pleura of
rabbit and sheep, and human primary cells (Sironi et al., 2007,
2008). Functional properties were analyzed by experiments using
the SGLT-blocker phloricin in the hydrothorax model, which
reduced water absorption from the pleural space (Zocchi et al.,
1996). Na+-Glucose cotransport can be molecular candidate for
solute-coupled absorption of liquid from the pleural space, indi-
cating an epithelial phenotype as also found e.g., in intestine and
kidney.
Taken together the analyses of transport function, a clear
indication of a typical epithelial phenotype is not given. To
discriminate an epithelial phenotype in more detail, a lateral dif-
fusion ofmolecules has to be restricted by tight junctions, though.
As epithelial cells typically show a tissue- and organ-specific
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expression pattern of claudins, these proteins may provide more
insight regarding the epithelial functions of pleura.
PHYSIOLOGICAL CONTRIBUTION OF TIGHT JUNCTION
PROTEINS
The ignition of molecular tight junction protein research
occurred in 1993, when the group of Shoichiro Tsukita described
the first discovery of a molecular correlate of barrier function,
namely occludin (Furuse et al., 1993). Before this time point, it
was even not clear if the tight junction, which had been visual-
ized in electron microscopic images for decades before, was of
protein or lipoid origin. This finding soon catalyzed the estab-
lishment of a new research field, resulting in a broad variety of
novel basic physiological as well as clinically related findings. Soon
after Tsukita’s pioneer work in the field of molecular tight junc-
tion analysis, a second landmark paper was published, this time
presenting the first members of the family of claudins, namely
claudin-1 and -2. Paralleled by the finding that occludin might
not be the most crucial factor for barrier integrity, as the com-
plete knock out did not show a perturbation of barrier properties
(Furuse et al., 1998; Schulzke et al., 2005), a series of further publi-
cations highlighted the functional contribution of single claudins
to major epithelial functions (Amasheh et al., 2011). These stud-
ies led to a classification of single members of the claudin family
in barrier building (sealing), pore-forming (paracellular chan-
nel function) and intermediate claudins, which still is valid and
can be regarded as a general outcome of tight junction research.
Finally, a third type of tight junction protein was described, which
led to a novel classification of non-claudin tight junction proteins
as members of the TAMP family, namely tricellulin, MarvelD3,
and occludin (Ikenouchi et al., 2005; Steed et al., 2009).
Among the variety of tetraspan TJ proteins that have been
reported to be localized within TJ strands of different organs,
occludin (Furuse et al., 1993) and claudins (Furuse et al., 1993)
have been identified to primarily provide a barrier against the
paracellular passage of ions. Although occludin was the first
tetraspan membrane protein that was detected within TJ strands
(Furuse et al., 1993), its contribution to barrier properties is still
discussed, though (Schulzke et al., 2005). At least, ubiquitous
detection in immunofluorescent stainings, established occludin
as a general marker of TJ localization, which has been evaluated
in many studies (Amasheh et al., 2002, 2005, 2009a,b; Dittmann
et al., 2014; Markov et al., 2014). Moreover, occludin can also be
visualized in pleura (Figure 3).
In contrast, members of the claudin family have been
attributed to the organ-specific properties of epithelia, as e.
g. shown in intestine, mammary gland, kidney and lungs
(Kaarteenaho et al., 2010; Kirk et al., 2010; Markov et al., 2010,
2012). The single contribution of claudins to barrier properties
varies, though. As e.g., claudin-1, -3, and -5, decrease tight junc-
tional ion permeability, other claudins have been demonstrated
to specifically mediate paracellular permeability, as it has been
shown in detail for claudin-2 which forms a paracellular channel
(Amasheh et al., 2002, 2005; Furuse et al., 2002; Milatz et al.,
2010).
Information on the molecular correlate of barrier function in
the pleura reaches back to the pre-molecular era of tight junction
research, when desmosomes and TJs have been discovered as
intercellular contacts by electron microscopy (Wang, 1974), and
a final breakthrough was achieved by detection of claudins and
the correlation with functional barrier properties (Markov et al.,
2011).
Recently, for the first time a combined analysis of pleura
mesothelial barrier function and expression of TJ proteins was
performed. In this study, claudin-1, -3, -5, and -7, were detected
in visceral pleura. In parietal pleura, the same TJ proteins
were detected, except claudin-7 (Markov et al., 2011; Figure 4).
Moreover, in inflamed pleura, claudin-2 was induced, indicating
a typical pathophysiological mechanism (see paragraph 4).
According to the functional contribution to barrier prop-
erties, claudins can be divided in three groups, namely (i)
sealing tight junction proteins, (ii) claudins mediating para-
cellular permeability and (iii) claudins with ambiguous func-
tion. Among the claudins detected in pleura mesothelium,
claudin-1, -3, and -5 belong to the first group, whereas
claudin-2 belongs to the second, and claudin-7 to the third
group.
FIGURE 3 | Detection of tight junction proteins in pleural cells.
Immunostaining of occludin with anti-occludin (green), detected by confocal
laser scanning microscopy reveals a honeycomb-like distribution of tight
junctions in pleural cells (visceral pleura, typical experiment, nuclei stained
in blue, bar: 5μm).
FIGURE 4 | Claudins of visceral and parietal pleura.
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PLEURA PROTEINS WITH PORE FORMING, SEALING, AND AMBIGUOUS
FUNCTION
Claudin-1-deficient mice die within hours after birth because of
dehydration. These animals show a severe weight loss due to evap-
oration of water through the skin (Furuse et al., 2002). Therefore,
claudin-1 is regarded as one major barrier-building TJ protein.
The functional contribution of claudin-3 has been analyzed
in detail by analysis of stably transfected cells, recently (Milatz
et al., 2010). This study demonstrates a strong sealing effect on
the paracellular pathway regarding the passage of cations, anions,
and uncharged solutes. These findings are in accordance with
the literature, which reports a ubiquitous presence of claudin-3
in many epithelia including kidney and intestine (Kiuchi-Saishin
et al., 2002; Markov et al., 2010).
Sealing properties of claudin-5 have been analyzed in detail in
both knock out experiments, and stable transfection of epithe-
lial cells (Nitta et al., 2003; Amasheh et al., 2005). Moreover,
recent findings suggest that apart from a tightening of the para-
cellular barrier against the passage of ions, also the passage of
uncharged molecules up to a size of 330 Da is restricted by
claudin-5 (Dittmann et al., 2014). Taken together a combina-
tion of claudin-1, -3, and -5 can also be found in other epithelia
with distinct barrier properties such as the gastrointestinal tract
(Markov et al., 2010) and airway epithelium (Coyne et al., 2003).
In contrast to clearly defined claudin properties outlined
above, the contribution of claudin-7 to barrier properties is still
discussed, as cell type specific differences were observed concern-
ing Cl− and Na+ permeability (Alexandre et al., 2005; Hou et al.,
2006).
The obtained results indicate that barrier properties of both
parietal and visceral pleura mesothelium participate in the for-
mation and determination pleural liquid ionic composition, and
different expression levels of occludin, claudin-3, -5, and -7,
reflect different extent of functional contributions, respectively.
In contrast to the sealing properties provided by the majority
of claudins, claudin-2 has been identified to form a paracellu-
lar channel selective for small cations and water (Amasheh et al.,
2002; Rosenthal et al., 2010). As a TJ protein mediating paracel-
lular permeability, increased claudin-2 expression is discussed to
sustain and aggravate inflammation (Amasheh et al., 2009a,b).
PLEURAL TIGHT JUNCTIONS IN HEALTH AND DISEASE
The expression of claudin-1, -3, -5, and -7 in human pleura
indicates an important role of specific barrier properties of the
mesothelial cell layers (Markov et al., 2011). These findings are
in accordance with previous studies, which have underlined spe-
cific contributions of single members of the tight junction protein
family of claudins to barrier function of other leaky epithelia
such as small intestine and proximal tubule (Markov et al., 2010;
Amasheh et al., 2011).
Expression of claudins in pleura mesothelium has been shown
to be altered in several pathophysiological conditions. These
changes can be found in inflammatory events and in cancer.
In previous studies, the paracellular channel claudin-2 has been
reported to be induced by tumor necrosis factor α (TNFα), which
explains e.g., the pathomechanism of inflammatory bowel dis-
eases (Amasheh et al., 2009a, 2010). The two main forms of
inflammatory bowel diseases, namely Crohn’s disease and ulcera-
tive colitis, as well as collagenous colitis and pouchitis, all typically
show a perturbation of TJ protein expression and localization.
This mechanism is regarded to be an important factor for the
sustained and aggravated course of the diseases mediated by
TNFα (Bürgel et al., 2002; Heller et al., 2005; Zeissig et al., 2007;
Amasheh et al., 2009a).
In inflamed pleura, a general reduction of tightening TJ pro-
teins and an increase of permeability mediating TJ proteins was
reported, recently (Markov et al., 2011). Claudin-2 was reported
to be elevated in inflamed pleura, which has also been shown
for Crohn’s disease, ulcerative colitis, and pouchitis (Heller et al.,
2005; Zeissig et al., 2007; Amasheh et al., 2009a). Moreover, in
inflamed pleura, a decrease of occludin, claudin-1, -3, -5, and
-7 was detected, which also shows parallels with mechanisms
reported in inflammatory bowel diseases (Heller et al., 2005;
Zeissig et al., 2007; Amasheh et al., 2009a).
In accordance, pleural exudates showed a marked increase of
TNFα levels in a mouse lung inflammation model (Mazzon and
Cuzzocrea, 2007). Moreover, TNFα is also elevated in other lung
pathologies, e.g., tuberculosis and cancer (Qian et al., 2012).
TNFα at higher levels was reported to induce a down-
regulation of the tight junction scaffolding protein zonula occlu-
dens protein 1 (ZO-1), and an opening of the paracellular barrier
(Ma et al., 2004). As a prerequisite of the pathomechanism of
TNFα altering tight junction protein expression in lungs, the
TNFα receptor TNFR1 was identified (Mazzon and Cuzzocrea,
2007). If, apart from claudin-2, a number of tightening tight
junction proteins are reduced due to a general perturbation of
ZO-1, this results in a decrease of barrier properties despite reduc-
tion of the paracellular pore claudin-2 (Schneeberger and Lynch,
1992; Fink and Delude, 2005; Jacob et al., 2005), though. Taken
together, whereas the increase of claudin-2 in pleural inflam-
mation indicates a separate regulatory pathway which has been
reported for inflammatory bowel diseases, the general reduction
of tightening proteins in inflamed pleura also points at a mecha-
nism reported in a mouse lung inflammation model, which is not
even based on an increase of claudin-2, but a universal decrease
of tight junction proteins which may less specifically perturb the
epithelial barrier. Both regulatory pathways however appear to be
primarily targeted by TNFα.
These alterations in claudin expression are in contrast to find-
ings reported in analyses of pleura cancer and mesothelioma,
which show an alteration of claudin-4. In this context, Claudin
4 was identified to be an important marker for carcinoma vs.
mesothelioma diagnosis in pleural and peritoneal biopsies and
effusions, as it is detected in metastatic tumor cells but not in
benign forms of mesotheliomas (Facchetti et al., 2007; Lonardi
et al., 2011).
CONCLUSIONS
Transport and barrier function of pleura mesothelium indicate
typical epithelial characteristics. Expression of the major seal-
ing tight junction proteins-1, -3, and -5 indicate a physiological
role of the mesothelial barrier function for pleural liquid forma-
tion. Moreover, the effects observed in inflamed pleura, namely
an induction of the paracellular pore claudin-2 and the decrease
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of tightening tight junction proteins are in accordance with reg-
ulatory mechanisms observed in inflamed epithelia, as shown
e.g., for inflammatory bowel diseases. These findings may con-
tribute to future therapeutic and preventive approaches regarding
mesothelia.
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